Labour-inhibiting drugs;Wehenhemmende medikamente

Geburtshilfe und Frauenheilkunde

Volumn 57, Issue 12, 1997, Pages 647-657

  Ziegler, A ^a   Baltzer, J ^b,c  

^a UNIVERSITY OF KIEL   (Germany)

^b Klinikum Krefeld

^c Klinikum Krefeld   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ANTAGONIST; CLENBUTEROL; FENOTEROL; MAGNESIUM; NIFEDIPINE; NORADRENALIN; OXYTOCIN ANTAGONIST; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE INHIBITOR; RITODRINE; SULINDAC; TERBUTALINE;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BETA ADRENERGIC STIMULATION; CARDIOSELECTIVITY; ENZYME INHIBITION; FETUS OUTCOME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PREMATURE LABOR; TOCOLYSIS;

EID: 0031466286     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1023154     Document Type: Article

References (111)

1. Äkerlund, M., P. Strömberg, A. Hauksson, L. F. Andersen, J. Lyndrup, J. Trojnar, P. Melin: Inhibition of uterine contractions of premature labour with an oxytocin analogue. Brit. J. Obstet. Gynaecol. 94 (1987) 1040-1044.
2. Alexandrova, M., M. S. Soloff: Oxytocin receptors and parturition. I Control of oxytocin receptor concentration in the rat myometrium at term. Endocrinology 106 (1980) 730-735.
3. Beall, M. H., B. W. Edgar, A. H. Paul, T. Smith-Wallace: A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor. Amer. J. Obstet. Cynecol. 153 (1985) 854-859.
4. Besinger, R. E., J. R. Niebyl: The safety and efficacy of tocolytic agents for the treatment of preterm labor. Obstet. Gyneacol. Surv. 45 (1990) 415-440.
5. Besinger, R. E., J. R. Niebyl, W. G. Keyes, T. R. B. Johnson: Randomized comparative trial of indomethacin and ritodrine for the long term treatment of preterm labor. Amer. J. Obstet. Gynecol. 164 (1991) 981-988.
6. Bracero, L. A., E. Leikin, N. Kirshenbaum, N. Tejani: Comparison of nifedipine and ritodrine for the treatment of preterm labor. Amer. J. Perinatol. 8 (1991) 365-369.
7. Brummer, H. C.: Interaction of E prostaglandins and syntocinon on the pregnant human myometrium. J. Obstet. Gyneacol. 78 (1970) 305-309.
8. Caldeyro-Barcia, R., J. Sereno: The response of the human uterus to oxytocin throughout pregnancy. In: Caldeyro-Barcia, R., H. Heller (eds.): Oxytocin. Pergamon Press, Oxford 1961 (pp 177-202).
9. Caritis, S. N., D. Carson, D. Greebon, M. McCormick, D. I. Edelstone, E. Müller-Heubach: A comparison of terbutaline and ethanol in the treatment of preterm labor. Amer. J. Obstet, Gynecol. 142 (1982) 183-190
10. Carlan, S. J., W. F. O'Brien, M. H. Jones, T. D. O'Leary, L Roth: Outpatient oral sulindac to prevent recurrence of preterm labor. Obstet. Cynecol. 85 (1995) 769-774.
11. Castrén, O., M. Gummerus, S. Saarikoski: Treatment of imminent premature labour. Acta Obstet. Gynecol. Scand. 54 (1975) 95-100.
12. Chau, A. C., H. A. Gabert, J. M. Miller: A prospective comparison of terbutaline and magnesium for tocolysis. Obsret. Gynecol. 80 (1992) 847-851
13. Clegg, P. C., W. J. Hall, V. R. Pickles: The action of ketonic prostaglandins on the guinea pig myometrium. J. Physiol. (Lond.) 183 (1966) 123-146.
14. Cole, W. C., R. E. Garfield: Evidence for physiological regulation of myometrial gap junction permeability. Amer. J. Physiol. 251 (1986) C411-C420.
15. Cooper, R. L., R. L. Goldenberg, R. K. Creasy, M. B. duBard, R. O. Davis, S. S. Entman, J. C. Iams, S. P. Cliver: A multicenter study of preterm birth weight and gestational age specific mortality. Amer. J. Obstet. Gynecol. 168 (1993) 78-83.
16. Cotton, D. B., H. T. Strassner, L. M. Hill, B. S. Schufrin, R. H. Paul: Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. J. Reprod. Med. 29 (1984) 92-97.
17. Cox, S. M., L. Sherman, K. J. Leveno: Randomized investigation of magnesium sulfate for prevention of premature labor. Amer. J. Obstet. Cynecol. 163 (1990) 767-772.
18. Ducsay, C. A., S. Thompson, A. T. Wu, M. J. Novy: Effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques: fetal plasma concentrations and cardiorespiratory changes. Amer. J. Obstet. Gynecol. 157 (1987) 1482-1486.
19. Elliot, J. P.: Magnesium sulfate as a tocolytic agent. Amer. J. Obstet. Gynecol. 147 (1983) 277-284.
20. Erny, R., A. Pigne, C. Prouvost, M. Gamerre, C. Malet, H. Serment, J. Barrat: The effect of oral administration of progesterone for premature labor Amer. J. Obstet. Gynecol. 154 (1986) 525-552
21. Eronen, M., E. Personen, T. Kurki, O. Ylikerkola, M. Hallman: Effect of indomethacin and a ß-sympathomimetic on the fetal ductus arteriosus during treatment of premature labor: A randomized double blind study. Amer. J. Obstet. Cynecol. 164 (1991) 141-146.
22. Ferguson, J. E., J. C. Dyson, T. Schutz: A comparison of tocolysis with nifedipine and ritodrine: Analysis of efficacy and maternal, fetal and neonatal outcome. Amer. J. Obstet. Gynecol. 163 (1990) 105-111.
23. Finley, J., M. Katz, M. Rojas-Perez, J. M. Roberts, R. K. Creasy, N. B. Schiller: Cardiovascular consequences of beta-agonist tocolysis: an echocardiographic study. Obstet. Gynecol. 64 (1984) 787-791.
24. Forman, A., K.-E, Andersson, U. Ulmsten: Inhibition of myometrial activity by calcium antagonists. Sem. Perinatol. 5 (1981) 288.
25. Fuchs, A. R.: The role of oxytocin in parturition. In Huszar, G. (ed.): The physiology and biochemistry of the uterus in pregnancy and labor. CRC-Press Boca-Raton Florida USA 1986 (S. 163-183).
26. Fuchs, A. R., F. Fuchs, P. Husslein, M. S. Soloff: Oxytocin receptors in the human uterus during pregnancy and parturition. Amer. J. Obstet. Cynecol. 150 (1984) 734-741.
27. Fuchs, A, R., F. Fuchs, P. Husslein, M. S. Soloff, M. J. Fernström: Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labor. Science 5 (1982) 1396-1398.
28. Fuchs, F.; Treatment of threatened premature labor with alcohol. J. Obstet. Gynaecol. Brit. Commonw. 72 (1965) 1011.
29. Fuchs, F., G. Wagner: Effect of alcohol on release of oxytocin. Nature 198 (1963) 92-94.
30. Fuchs, A. R., S. Periyasamy, M. Alexandrova, M. S. Soloff: Correlation between oxytocin receptor concentration and responsiveness to oxytocin in pregnant rat myometrium: Effects of ovarian steroids. Endocrinology 113 (1983) 2-749.
31. Garfield, R. E., S. Sims, E. E. Daniel: Gap junctions: their presence and necessity in myometrium during parturition. Science 198 (1977) 958-959.
32. Garfield, R. E.: Structural and functional studies of the control of myometrial contractility and labor. In: McNellis, D., J. R. G. Challis, P. C MacDonald, P. W. Nathanielsz, J. M. Roberts (eds.): The onset of labor. Perinatology Press, Ithaca 1988 (pp 55-80).
33. Garfield, R. E., R. H. Hayashi: Appearance of gap junctions in the myometrium of women during labor. Amer. J. Obstet. Gynecol. 140 (1981) 254-260.
34. Garfield, R. E., C. P. Puri, A. I. Csapo: Endocrine, structural and functional changes in the uterus during premature labor. Amer. J. Obstet. Gynecol. 142 (1982) 21-27.
35. Gibbens, D., T. Chard: Observations on maternal oxytocin release during human labor and the effect of intravenous alcohol administration. Amer. J. Obstet. Gynecol. 126 (1976) 243.
36. Golichowski, A. M., D. R. Hathaway, N. Fineberg, D. Peleg: Tocolytic and hemodynamic effects of nifedipine in the ewe. Amer. J. Obstet. Gynecol. 151 (1985) 1134-1140.
37. Goodwin, T. M., R. Paul, H. Silver, W. Spellacy, M. Parsons, R. Chez, R. Hayashi, G. Valenzuela, G. W. Creasy, R. Merriman: The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Amer. J. Obstet. Gynecol. 170 (1994) 474-480.
38. Halberstadt, E., R. Schuhmann, R. Gerener, H. Roos: Die enterale Gabe von Clenbuterol zur Tokolyse. In: Jung, H., F. H. Fendel, C. Karl (Hrsg.): Neueste Ergebnisse über Betamimetika. Steinkopff-Verlag, Darmstadt 1986 (S. 88-98).
39. Harbert, G. M., G. W. Cornell, W. N. Thornton: Effect of toxemia therapy on uterine dynamics. Amer. J. Obstet. Gynecol. 105 (1969) 94-104.
40. Hendrix, E. M., L. Myatt, S. Sellers, P. T. Russell, W. J. Larsen: Steroid hormone regulation of rat myometrial gap junction formation: Effects on cx43 levels and trafficking. Biol. Reprod. 52 (1995) 547-560.
41. Holcomb, W. L., G. D. Shackleford, R. G. Petrie: Magnesium tocolysis and neonatal bone abnormalities: A controlled study. Obstet. Gynecol. 78 (1991) 611-614.
42. Hollander, D. I., D. A. Nagey, M. J. Pupkin: Magnesium sulfate and ritodrine hydrochloride: A randomized comparison. Amer. J. Obstet. Gynecol. 156 (1987) 433-438.
43. Holbrook, R. H., M. Lirette, M. Katz: Cardiovascular and tocolytic effects of mcardipine HCl in the pregnant rabbit: comparison with ritodrine HCl. Obstet. Gynecol. 69 (1987) 83-87.
44. How, H. Y., S. A. Hughes, R. L. Vogel, S. A. Gall, J. A. Spinnato: Oral terbutaline in the outpatient management of preterm labor. Amer. J. Obstet. Gynecol. 173 (1995) 1518-1522.
45. Ingemarsson, I.: Effect of terbutaline on premature labor - a double blind placebo-controlled study. Amer. J. Obstet. Gynecol. 125 (1976) 520-524.
46. Irmer, M., R. Trolp, B. Schmid-Redemann, H. G. Hillemanns: Auswirkungen einer Tokolysetherapie mit Fenoterol/Verapamil und Fenoterol/Metoprolol auf das mütterliche und kindliche Herz. Arch. Gynecol. 232 (1981) 519.
47. Johnson, J. W. C., K. L. Austin, G. S. Jones, K. H. Davis, T. M. King: Efficacy of the 17-α-hydroxy-progesterone-caproat in the prevention of premature labor. New Engl. J. Med. 293 (1975) 675-680.
48. Kao, C. Y.: Electrophysiological properties of the uterine smooth muscle. In Wynn, R. M.: Biology of the uterus, 2nd ed. Plenum Press, New York 1977 (S. 423-496).
49. Kaul, A. F., R. Osathanondh, L. E. Safon, F. D. Frigolette, P. A. Friedma: The management of preterm labor with the Ca-channel blocking agent nifedipine combined with the beta-mimetic terbutaline. Drug. Intell. Clin. Pharmacol. 19 (1985) 369-371.
50. Keirse, M. J.: Progesterone administration in pregnancy may prevent preterm delivery. Brit. J. Obstet. Gynaecol. 97 (1990) 149-154.
51. van Kets, H., M. Thiery, R. Derom, H. van Egmond, G. Baele: Perinatal hazards of chronic antenatal tocolysis with indomethacin. Prostaglandins 18 (1979) 893-907.
52. King, J. F., A. Grant, M. J. N. C. Keirse, I. Chalmer: Beta-mimetics in preterm labour: An overview of the randomized controlled trials. Brit. J. Obstet. Gynaecol. 95 (1988) 211-222.
53. Kofinas, A. D., J. C. Rose, D. R. Koritink, P. J. Meis: Progesterone and estradiol concentrations in non pregnant human myometrium: Effect of progesterone and estradiol on cyclic adenosine monophosphate. J. Reproduce Med. 35 (1990) 1045-1050.
54. Lamm, C. I., K. I. Norton, R. J. Muphy, I. A. Wilkins, J. G. Rabinowitz: Congenital rickets associated with magnesium sulfate infusion for tocolysis. J. Pediatr. 113 (1988) 1078-1082.
55. Levis, R. B., J. D. Schulman: Influence of acetylsalicytic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labor. Lancet (II) (1973) 1159-1161.
56. López-Bernal, A., G. N. Europe-Finne, S. Phaneuf, S. P. Watson: Preterm labour: a pharmacological challenge. Trends Pharmacol. Sci. 16 (1995) 129-133.
57. MacKenzie, L. W., R. E. Garfield: Hormonal control of gap junctions in the myometrium. Amer. J. Physiol. 248 (1985) C296-C308.
58. Macones, G. A., C. Robinson: Is there a justification for using mdomethacin in preterm labor? An analysis of neonatal risks and benefits. Amer. J. Obstet. Gynecol. 176 (1997) S46.
59. Madden, S., J. Owen, J. C. Hauth: Magnesium tocolysis: Serum levels versus success. Amer. J. Obstet. Gynecol. 162 (1990) 1177-1180.
60. Martin, R. W., D. K. Gaddy, J. N. Martin, J. A. Lucas, W. L. Wiser, J. C. Morrison: Tocolysis with oral magnesium. Amer. J. Obstet. Gynecol. 156 (1987) 433-434.
61. Martin, R. W., K. G. Perr, L. W. Hess, J. N. Martin, J. C. Morrison: Oral magnesium and the prevention of preterm labor in a high risk group of patients. Amer. J. Obstet. Gynecol. 166 (1992) 144-147.
62. McCormick, M.: Trends in rates of low birthweight in the United States. In: Berendes, H. W., S. Kessel, S. Yaffe (eds.): Advances in the prevention of low birthweight. NtI. Center Edu. Mat. and Child Health, Washington, DC 1991 (3-11).
63. Melin, P., H. Vilhardt, G. I. Lindberg: Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity. J. Endocrinol. 88 (1981) 173-180.
64. Meyer, W. R., H. W. Randall, W. L. Graves: Nifedipine versus ritodrine for suppressing preterm labor. J. Reproduct. Med. 35 (1990) 649-653.
65. Moise, K. J., J. C. Huhta, D. S. Sharif, C. N. Ou, B. Kirshon, N. Wasserstrum, L. Cano: Indomethacin in the treatment of premature labor. New Engl. J. Med. 319 (1988) 327-331.
66. Monga, M., R. K. Creasy: Pharmacological management of preterm labor. Sem. Perinatol. 19 (1995) 84-96.
67. Morales, W. J., S. G. Smith, J. L. Angel, W. F. O'Brien, R. A. Knuppel: Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: A randomized study. Obstet. Gynecol. 74 (1989) 567-572.
68. Morales, W. J., H. Madhav: Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: A randomized study. Amer. J. Obstet. Gynecol. 169 (1993) 97-102.
69. Mordes, J. P., W. E. Wacker: Excess magnesium. Pharmacol. Rev. 29 (1978) 273-300.
70. Murray, C., A. D. Haverkamp, M. Orleans, S. Berga, D. Pecht: Nifedipine for treatment of preterm labor: a historic prospective study. Amer. J. Obstet. Gynaecol. 167 (1992) 52-56.
71. Novy, M. J., M. J. Cook, L. Manaugh: Indomethacin block of normal onset of parturition in primates. Amer. J. Obstet. Gynaecol. 8 (1974) 412-416.
72. Niebyl, J. R., D. A. Blake, R. D. White et al.: The inhibition of premature labor with indomethacin. Amer. J. Obstet. Gynecol. 136 (1980) 1014-1019.
73. Norton, M. E., J. Merill, B. A. B. Cooper, C. A. Kuller, R. I. Clyman: Neonatal complications after administration od indomethacin for preterm labor. New Engl. J. Med. 329 (1993) 1602-1607.
74. Panter, K., B. Tan, M. Hannah: Indomethacin versus ß-mimetics for the tocolysis of preterm labor: a meta-analysis of RCTs. Amer. J. Obstet. Gynecol. 174 (1996) 466.
75. Panter, K., M. Hannah, D. Farine, K. Amankwah, A. Jefferies, A. Ohlson: The effect of indomethacin tocolysis of preterm labor on perinatal outcome. Amer. J. Obstet. Gynecol. 176 (1997) S46.
76. Peek, M. J., A. Mc Carthy, P. Kyle, W. Sepulveda, M. M. Fisk: Medical amnioreduction with sulindac to reduce cord complications in monoamniotic twins. Amer. J. Obstet. Gynecol. 176 (1997) 334-336.
77. Petrie, R. H.: Tocolysis using magnesium sulfate. Sem. Perinatol. 5 (1981) 266-273.
78. Peyron, R., E. Aubény, V. Targosz, L. Silvestre, M. Renault, F. Elkik, P. Leclerc, A. Ulman, E.-E. Baulieu: Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. New Engl. J. Med. 328 (1993) 1509-1513.
79. Pollard, J. K., M. D. Mitchell: Intrauterine infection and the effects of inflammatory mediators on prostaglandin production by myometrial cells from pregnant women. Amer. J. Obstet. Gynecol. 174 (1996) 682-686.
80. Randall, R. E., M. D. Cohen, C. C. Spray, E. C. Rossmeisl: Hypermagnesemia in renal failure. Etiology and toxic manifestations. Ann. Intern. Med. 61 (1964) 73-88.
81. Read, M. D., D. E. Wellby: The use of a calcium antagonist (nifedipine) to suppress preterm labor. Brit. J. Obstet. Gynaecol. 93 (1986) 933-937.
82. Ricci, J. M., S. Hariharan, A. Helfgott, K. Reed, M. J. O'Sullivan: Oral tocolysis with magnesium chloride: A randomized controlled prospective clinical trial. Amer. J. Obstet. Gynecol. 165 (1991) 603-609.
83. Roberts, J. M.: Current understanding of pharmacologic mechanisms in the prevention of preterm birth. Clin. Obstet Gynaecol. 27 (1984) 592-605.
84. Romero, R., M. Mazor, Y. K. Wu, M. Sirtori, E. Oyarzuri, M. D. Mitchell, J. C. Hobbins: Infection in the pathogenesis of preterm labor. Semin. Perinatol. 12 (1988) 262-279.
85. Silvestre, L., C. Dubois, M. Renault, Y. Rezvani, E.-E. Baulieu: Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. New Engl. J. Med. 322 (1990) 645-648.
86. Soloff, M. S.: The role of oxytocin in the initiation of labor, and oxytocin-prostaglandin interactions. In: McNellis, D., J. R. G. Challis, P. C. MacDonald, P. W. Nathanielsz, J. M. Roberts (eds.): The onset of labor. Perinatology Press, Ithaca 1988 (pp 87-110).
87. Spellacy, W. N., A. C. Cruz, S. A. Birk, W. C. Buhi: Treatment of premature labor with ritodrine: a randomized controlled study. Obsret. Gynecol. 54 (1979) 220-223.
88. Steer, C. M., R. H. Petrie: A comparison of magnesium sulfate and alcohol for the prevention of premature labor. Amer. J. Obstet. Gynecol. 129 (1977) 1-4.
89. Stubbefield, P., D. Heyl: Treatment of premature labor with subcutaneous terbutaline. Obstet. Gynaecol. 59 (1982) 457-462.
90. Ulmsten, U.: Treatment of normotensive and hypertensive patients with premature labor using oral nifedipine, a calcium antagonist. Arch. Gynecol. 236 (1984) 69-72.
91. Ulmsten, U., K. E. Andersson, L. Wingerup: Treatment of premature labor with the Ca-antagonist nifedipine. Arch. Gynaecol. 229 (1980) 1-5.
92. Veille, J. C., J. M. Bissonnett, A. R. Hohimer: The effect of calcium channel blocker (nifedipine) on uterine blood flow in the pregnant goat. Amer. J. Obstet. Gynecol. 154 (1986) 1160-1163.
93. van der Veyer, I. B., K. J. Moise, C. N. Ou: The effect of gestational age and fetal indomethacin levels on the incidence of constriction of the fetal ductus arteriosus. Obstet. Gynecol. 82 (1994) 500-503.
94. Wagner, J. M., M. J. Morton, H. A. Johnson, J. P. O'Grady, L. Speroff: Terbutaline and maternal cardiac function. J. Amer. Med. Ass. 246 (1981) 2697-2701.
95. Walters, B. N. J., C. W. G. Redman: Treatment of severe pregnancy associated hypertension with the calcium antagonist nifedipine. Brit. J. Obstet. Gynaecol. 91 (1984) 330-336.
96. Wesselius-de Casparis, A., M. Thiery, A. Yo le Sian, K. Baumgarten, I. Brosens, O. Garrisons, J. G. Stolk, W. Vivier: Results of a double blind multicentre study with ritodrine in premature labor. Brit. med. J. 144 (1971) 144.
97. Wilkins, I. A., L. Lynch, K. E. Mehalek, K. S. Berkowitz, R. L. Berkowitz: Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents. Amer. J. Obstet. Gynecol. 159 (1988) 685-689.
98. Wiqvist, N., V. Lindström, K. Green: Premature labour and indomethacin. Prostaglandins 10 (1975) 515-526.
99. Wischnik, A., M. Hermer, W. Alberti: Clenbuterol als neues Tokolytikum zur oralen Anwendung - Klinische Ergebnisse. In Jung, H., F. H. Fendel, C. Karl (Hrsg.): Neueste Ergebnisse über Betamimetika. Steinkopff Verlag, Darmstadt 1986 (S. 88-98).
100. Wischnik, A., N. Mendler, W. Heimisch, A. Schroll, A. Weidenbach: Das kardiale Risiko bei Tokolyse und Möglichkeiten zu dessen Antagonisierung, Geburtsh. u. Frauenheilk. 42 (1982) 288-290.
101. Witlin, A. G., S. A. Friedman, B. M. Sibai: The effect of magnesium Sulfate therapy on the duration of labor in women with mild preeclampsia at term: A randomized double-blind, placebo-controlled trial. Amer. J. Obstet. Gynecol. 176 (1997) 623-627.
102. de Wits, W., I. van Mourik, P. E. Wiesenhaan: Prolonged maternal indomethacin therapy associated with oligohydramnios: case reports. Brit. J. Obstet. Gynaecol. 95 (1988) 303-305.
103. Wolff, F.: Standortbestimmung der Tokolysebehandlung 1994.
104. Yallampalli, C., R. E. Garfield: Uterine contractile response to endothelin-1 and endothelin receptors are elevated during labor. Biol. Reprod. 51 (1994) 640-645.
105. Yallampalli, C., R. E. Garfield, M. Byam-Smith: Nitric oxide inhibits uterine contractility during pregnancy but not during delivery. Endocrinol. 133 (1993) 1899-1902.
106. Yeagley, C. S. N. Caritis, A. L. Ruzycki: Contraction inhibition by β-agonists progressively decreases before labor in the rat myometrium. Amer. J. Obstet. Gynecol. 174 (1996) 1673-1680.
107. Zervoudakis, I. A., A. Krauss, F. Fuchs: Infants of mothers treated with ethanol for premature labor. Amer. J. Obstet. Gynecol. 137 (1980) 713-718.
108. Zlatnik, F. J., F. Fuchs: A controlled study of ethanol in the threatened premature labor. Amer. J. Obstet. Gynecol. 112 (1972) 610.
109. Zuckerman, H., U. Reiss, I. Rubinstein: Inhibition of human premature labour by indomethacin. Obstet. Gynecol. 44 (1975) 787-792.
110. Zuckerman, H., E. Shalev, G. Gilad, E. Katzuni: Further study of the inhibition of premature labor by indomethacin (I), J. Perinatol. Med. 12 (1984) 19-23.
111. Zuckerman, H., E. Shalev, G. Gilad, E. Katzuni: Further study of the inhibition of premature labor by indomethacin (II). Double blind study. J. Perinatol. Med. 12 (1984) 25-29.